Clinical Trials Browser

Neoplasm Metastasis × pembrolizumab × NET × Clear all

NCT02939651 2021-03-09

A Study of Pembrolizumab in Patients With Neuroendocrine Tumors

Phase 2 Completed

21 enrolled 10 charts

Neoplasm Metastasis, Neuroendocrine Tumors